Boston Medical Center
Boston, Massachusetts, 02118, United States
NCT Number: NCT00987961
This study tests whether starting Suboxone (buprenorphine) during a medical hospitalization, and then providing an appointment (a "link") for after discharge to maintenance buprenorphine in an outpatient setting will reduce HIV risk behavior in individuals who inject opioids.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Phase 3
Boston, Massachusetts, 02118, United States
In this randomized controlled trial, medically hospitalized opioid dependent patients will be assigned to a "treatment as usual" group, where they will receive a detox regiment of Suboxone during their hospital stay, or a "linkage" group, where they receive a maintenance course of Suboxone during their hospital stay, and appointment post-discharge with an outpatient Suboxone clinic/provider and a Suboxone prescription to use between discharge and this appointment. Study interviews are completed at baseline, and 1, 3- and 6-months post-baseline. Primary outcomes are opioid use and HIV risk behavior.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This intervention provides an outpatient appointment with a Suboxone provider for medically hospitalized opioid-dependent patients to attend post-discharge.
Time frame: baseline, 1-month, 3-months, 6-months
Time frame: baseline, 1-month, 3-months, 6-months
Time frame: baseline, 1-month, 3-months, 6-months
Time frame: baseline, 1-month, 3-months, 6-months
Butler Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03718065
Chemically-Induced Disorders, Mental Disorders
Charleston, South Carolina, United States
View Trial DetailsNCT03527485
Chemically-Induced Disorders, Cocaine Dependence
New Haven, Connecticut, United States
View Trial DetailsNCT03769025
Chemically-Induced Disorders, Mental Disorders
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT04156802
Back Pain, Chemically-Induced Disorders
Winston-Salem, North Carolina, United States
View Trial Details